Cisen Pharmaceutical Co (SHSE:603367) E10: ¥1.04 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603367 Cisen Pharmaceutical Co Ltd SHSE:603367
66 GF Score
Price ¥14.13
GF Value ¥15.19
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Cisen Pharmaceutical Co E10?

Cisen Pharmaceutical Co SHSE:603367 +0.57% 66 E10 is ¥1.04 as of Mar. 2026. GuruFocus rates SHSE:603367 with a GF Score™ of 66/100 and a GF Value™ of ¥15.19 (Fairly Valued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cisen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.290. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥1.04 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-29), Cisen Pharmaceutical Co's current stock price is ¥14.13. Cisen Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥1.04. Cisen Pharmaceutical Co's Shiller PE Ratio of today is 13.59.

During the past 13 years, the highest Shiller PE Ratio of Cisen Pharmaceutical Co was 32.77. The lowest was 11.97. And the median was 15.12.


Cisen Pharmaceutical Co  (SHSE:603367) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cisen Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=14.13/1.04
=13.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Cisen Pharmaceutical Co was 32.77. The lowest was 11.97. And the median was 15.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cisen Pharmaceutical Co E10 Related Terms


Cisen Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Cisen Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cisen Pharmaceutical Co E10 Chart

Cisen Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.03 1.03

Cisen Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.04 1.03 1.04 1.03 1.04

SHSE:603367 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cisen Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cisen Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cisen Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cisen Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603367
66GF Score
Cisen Pharmaceutical Co Ltd SHSE:603367
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cisen Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cisen Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.29/116.3033*116.3033
=0.290

Current CPI (Mar. 2026) = 116.3033.

Cisen Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 100.600 0.000
201609 0.210 102.400 0.239
201612 0.240 102.600 0.272
201703 0.140 103.200 0.158
201706 0.220 103.100 0.248
201709 0.210 104.100 0.235
201712 0.390 104.500 0.434
201803 0.260 105.300 0.287
201806 0.260 104.900 0.288
201809 0.310 106.600 0.338
201812 0.280 106.500 0.306
201903 0.280 107.700 0.302
201906 0.280 107.700 0.302
201909 0.350 109.800 0.371
201912 0.230 111.200 0.241
202003 0.230 112.300 0.238
202006 0.170 110.400 0.179
202009 0.320 111.700 0.333
202012 0.250 111.500 0.261
202103 0.240 112.662 0.248
202106 0.160 111.769 0.166
202109 0.230 112.215 0.238
202112 0.110 113.108 0.113
202203 0.210 114.335 0.214
202206 0.200 114.558 0.203
202209 0.230 115.339 0.232
202212 0.130 115.116 0.131
202303 0.340 115.116 0.344
202306 0.240 114.558 0.244
202309 0.280 115.339 0.282
202312 0.290 114.781 0.294
202403 0.360 115.227 0.363
202406 0.240 114.781 0.243
202409 0.280 115.785 0.281
202412 0.240 114.893 0.243
202503 0.320 115.116 0.323
202506 0.190 114.907 0.192
202509 0.330 115.471 0.332
202512 0.090 115.832 0.090
202603 0.290 116.303 0.290

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥1.04 mean?
Cisen Pharmaceutical Co (SHSE:603367) has a E10 of ¥1.04 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cisen Pharmaceutical Co and its competitors.
Is Cisen Pharmaceutical Co's E10 too high?
Cisen Pharmaceutical Co's current E10 is ¥1.04. Overall, Cisen Pharmaceutical Co has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cisen Pharmaceutical Co's E10 compare to ZTS?
Cisen Pharmaceutical Co's E10 of ¥1.04 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Cisen Pharmaceutical Co and its competitors. Cisen Pharmaceutical Co's current E10 is ¥1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cisen Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Cisen Pharmaceutical Co (SHSE:603367) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.19, compared to a current price of ¥14.13 — trading 7% below its estimated fair value. The current E10 is ¥1.04. Cisen Pharmaceutical Co's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Cisen Pharmaceutical Co (SHSE:603367), the current E10 is ¥1.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cisen Pharmaceutical Co (SHSE:603367) Overvalued in 2026?

Based on GuruFocus' analysis, Cisen Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥14.13 is trading 7% below its estimated GF Value™ of ¥15.19. GuruFocus considers Cisen Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603367:

  • E10: ¥1.04
  • GF Value™: ¥15.19 vs. price of ¥14.13 (7% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the SHSE:603367 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cisen Pharmaceutical Co Business Description

Address Tongji Sci-tech Industrial Park, High-tech Industrial Development Zone, Shandong, Jining, CHN, 272073
Cisen Pharmaceutical Co Ltd is the pharmaceutical company in China. The company's main business is the development, production and sales of pharmaceutical products, mainly in the production of chemical preparations. Its product offering includes chemical drug preparations such as liver disease drug, antitumor and auxiliary drugs, nutrition preparation, cardiovascular class, antibiotics, sedation anaesthesia snooze, digestive system agents; and healthcare products.
66GF Score

Get the complete analysis for SHSE:603367

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.13
Price
¥15.19
GF Value